ANUSOL

This brand name is authorized in Australia, Ireland, United Kingdom

Active ingredients

The drug ANUSOL contains a combination of these active pharmaceutical ingredients (APIs):

1 Zinc
UNII SOI2LOH54Z - ZINC OXIDE

Zinc blocks the intestinal absorption of copper from the diet and the reabsorption of endogenously secreted copper. Zinc induces the production of metallothionein in the enterocyte, a protein that binds copper thereby preventing its transfer into the blood. The bound copper is then eliminated in the stool following desquamation of the intestinal cells.

Read about Zinc
2 Balsam Peru
UNII 8P5F881OCY - BALSAM PERU
3 Bismuth oxide
UNII A6I4E79QF1 - BISMUTH OXIDE

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C05AX04 Zinc preparations C Cardiovascular system → C05 Vasoprotectives → C05A Agents for treatment of hemorrhoids and anal fissures for topical use → C05AX Other agents for treatment of hemorrhoids and anal fissures for topical use
Discover more medicines within C05AX04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 4039N, 4040P
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 20736, 20738

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.